Are oligodendrocytes bystanders or drivers of Parkinson’s disease pathology?

• José María Salazar Campos,

  Affiliation Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, LMU Munich, Munich, Germany

  ⨯
• Lena F. Burbulla ,

  * E-mail: Lena.Burbulla@med.uni-muenchen.de (LFB); Sarah.Jaekel@med.uni-muenchen.de (SJ)

  Affiliations Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, LMU Munich, Munich, Germany, Munich Cluster for Systems Neurology (SyNergy), Munich, Germany, German Center for Neurodegenerative Diseases (DZNE), Munich, Germany

  ⨯
• Sarah Jäkel

  * E-mail: Lena.Burbulla@med.uni-muenchen.de (LFB); Sarah.Jaekel@med.uni-muenchen.de (SJ)

  Affiliations Munich Cluster for Systems Neurology (SyNergy), Munich, Germany, Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany

  https://orcid.org/0000-0002-9634-2472

  ⨯